Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Colorcon
Mallinckrodt
Daiichi Sankyo
Accenture
Chubb
Medtronic
Johnson and Johnson
Chinese Patent Office
Cipla

Generated: January 17, 2018

DrugPatentWatch Database Preview

Phentermine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phentermine hydrochloride and what is the scope of phentermine hydrochloride patent protection?

Phentermine hydrochloride
is the generic ingredient in eleven branded drugs marketed by Teva, Glaxosmithkline, Ferndale Labs, Shire Richwood, Mast Mm, Abc Holding, Able, Aurolife Pharma Llc, Barr, Camall, Chartwell Rx, Duramed Pharms Barr, Elite Labs, Elite Labs Inc, Invagen Pharms, Ivax Pharms, Ken Lifescience, Kvk Tech, Lannett, Lannett Holdings Inc, Mikah Pharma, Sandoz, Sun Pharm Industries, Tg United Inc, Upsher-smith Labs, Usl Pharma, Vitarine, Watson Labs, Zydus Pharms Usa Inc, Citius Pharms, Avanthi Inc, Actavis Elizabeth, Ingenus Pharms Nj, Kvk Tech Inc, Polygen Pharms, Prinston Inc, Sandoz Inc, Sun Pharm Inds Inc, Solvay, and Vivus, and is included in one hundred NDAs. There are thirteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Phentermine hydrochloride has fourteen patent family members in ten countries.

There are seventeen drug master file entries for phentermine hydrochloride. Forty-six suppliers are listed for this compound.
Summary for phentermine hydrochloride
Pharmacology for phentermine hydrochloride

US Patents and Regulatory Information for phentermine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Citius Pharms SUPRENZA phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 202088-003 Mar 27, 2012 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Lannett Holdings Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 201961-001 Jul 20, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 087190-001 Approved Prior to Jan 1, 1982 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivus QSYMIA phentermine hydrochloride; topiramate CAPSULE, EXTENDED RELEASE;ORAL 022580-001 Jul 17, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Teva ADIPEX-P phentermine hydrochloride TABLET;ORAL 085128-001 Approved Prior to Jan 1, 1982 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Camall PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 086735-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivus QSYMIA phentermine hydrochloride; topiramate CAPSULE, EXTENDED RELEASE;ORAL 022580-002 Jul 17, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Teva PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 087777-001 Nov 1, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 204663-002 Jun 28, 2017 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tg United Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 040083-001 Mar 7, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for phentermine hydrochloride

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Chubb
Queensland Health
Chinese Patent Office
US Army
Medtronic
Express Scripts
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot